HemoCath Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
HemoCath General Information
Description
Developer of an integrated hemodynamic monitoring and diagnostic system intended for the diagnosis, treatment, and monitoring of acute heart failure. The company's platform integrates a specialized pulmonary artery catheter, which is designed for safer arm insertion and provides reliable, continuous monitoring of crucial values with cloud-based artificial intelligence capabilities that interpret complex data streams and deliver real-time, data-driven insights and clinical guidance, enabling clinical teams to enhance care management decisions, which concurrently improves patient recovery trajectories and lowers institutional expenses associated with hospital admissions and readmissions for heart failure.
Contact Information
Website
www.hemocath.comCorporate Office
- Austin, TX
- United States
Corporate Office
- Austin, TX
- United States
HemoCath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 17-Apr-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 20-Aug-2021 | Completed | Generating Revenue |
HemoCath Patents
HemoCath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020359681-A1 | Multi-sensor catheter for right heart and pulmonary artery catheterization | Inactive | 30-Sep-2019 | ||
| EP-4041071-A1 | Multi-sensor catheter for right heart and pulmonary artery catheterization | Inactive | 30-Sep-2019 | ||
| EP-4041071-A4 | Multi-sensor catheter for right heart and pulmonary artery catheterization | Inactive | 30-Sep-2019 | ||
| US-12402797-B2 | Multi-sensor catheter for right heart and pulmonary artery catheterization | Active | 30-Sep-2019 | ||
| US-20220338745-A1 | Multi-sensor catheter for right heart and pulmonary artery catheterization | Active | 30-Sep-2019 | A61B5/6853 |
HemoCath Signals
HemoCath Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medlim | Accelerator/Incubator | |||
| Incubateur Impulse | Accelerator/Incubator | |||
| BE Health Ventures | Venture Capital | Minority |
HemoCath FAQs
-
When was HemoCath founded?
HemoCath was founded in 2013.
-
Where is HemoCath headquartered?
HemoCath is headquartered in Austin, TX.
-
What is the size of HemoCath?
HemoCath has 5 total employees.
-
What industry is HemoCath in?
HemoCath’s primary industry is Monitoring Equipment.
-
Is HemoCath a private or public company?
HemoCath is a Private company.
-
What is HemoCath’s current revenue?
The current revenue for HemoCath is .
-
Who are HemoCath’s investors?
Medlim, Incubateur Impulse, and BE Health Ventures have invested in HemoCath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process